← All news
Markets

Adaptive Biotechnologies CEO Chad Robins sells $14.88m in shares

1 source ·2 articles ·Aug 20, 02:36 UTC Adaptive Biotechnologies

Covered by 1 outlet

All coverage · 2 articles